Exact Mass: 320.0387392
Exact Mass Matches: 320.0387392
Found 338 metabolites which its exact mass value is equals to given mass value 320.0387392,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
trans-3,3',4',5,5',7-Hexahydroxyflavanone
(+)-dihydromyricetin is an optically active form of dihydromyricetin having (2R,3R)-configuration. It has a role as a metabolite, an antioxidant and an antineoplastic agent. It is a secondary alpha-hydroxy ketone and a dihydromyricetin. It is an enantiomer of a (-)-dihydromyricetin. Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus). Dihydromyricetin is a naturally occurring flavonoid found in the many plant species and is thought to be the active ingredient of several traditional Japanese, Chinese, and Korean medicines that are used to treat fever, parasite infections, liver diseases, and hangovers. Dihydromyricetin preparations have not been linked to instances of serum enzyme elevations or clinically apparent liver injury with jaundice. Dihydromyricetin is a natural product found in Vitis rotundifolia, Catha edulis, and other organisms with data available. (±)-trans-3,3,4,5,5,7-Hexahydroxyflavanone is found in tea. (±)-trans-3,3,4,5,5,7-Hexahydroxyflavanone is a constituent of Camellia sinensis (Chinese green tea). Constituent of Camellia sinensis (Chinese green tea). (±)-Dihydromyricetin is found in tea. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
Phenthoate
C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
2,3-Dihydrogossypetin
A member of the class of dihydroflavonols that is the 2,3-dihydro derivative of gossypetin.
lorazepam
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; INTERNAL_ID 1512 CONFIDENCE standard compound; INTERNAL_ID 8600 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3138
Lorazepam
Lorazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. [PubChem]Lorazepam binds to an allosteric site on GABA-A receptors, which are pentameric ionotropic receptors in the CNS. Binding potentiates the effects of the inhibitory neurotransmitter GABA, which upon binding opens the chloride channel in the receptor, allowing chloride influx and causing hyperpolerization of the neuron. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics
Erosnin
Erosnin is found in jicama. Erosnin is a constituent of the yam bean (Pachyrrhizus erosus) Constituent of the yam bean (Pachyrrhizus erosus). Erosnin is found in jicama and pulses.
5-Amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one
C16H11F3N2O2 (320.07725819999996)
3-Alizarinsulfonic acid
D004396 - Coloring Agents
7-(Benzyloxy)-4-(trifluoromethyl)-2H-chromen-2-one
Dehydrochloramphenicol
C11H10Cl2N2O5 (319.99667500000004)
Lonidamine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000988 - Antispermatogenic Agents D011838 - Radiation-Sensitizing Agents C1744 - Multidrug Resistance Modulator D000970 - Antineoplastic Agents Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki: 2.5 μM). Lonidamine also inhibits aerobic glycolysis in cancer cells. Lonidamine can be used in the research of mitochondrial metabolism and inflammation, such as pulmonary fibrosis[1][2][3].
(2S)-4,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-one
2-[1-(2-Fluorophenyl)ethylamino]-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4-one
Ethyl brevifolincarboxylate
Ethyl brevifolincarboxylate, also known as ebfc, belongs to isocoumarins and derivatives class of compounds. Those are polycyclic compounds containing an isochromane which bears a ketone at the carbon C1. Ethyl brevifolincarboxylate is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Ethyl brevifolincarboxylate can be found in pomegranate, which makes ethyl brevifolincarboxylate a potential biomarker for the consumption of this food product.
ampelopsin
Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
Methyl 2-cyano-3-{1-[4-(trifluoromethyl)phenyl]-1H-pyrrol-2-yl}acrylate
C16H11F3N2O2 (320.07725819999996)
1-(3-methoxyphenyl)-3-(methyl-oxo-phenyl-$l^{6}-sulfanylidene)thiourea
C15H16N2O2S2 (320.06531559999996)
2,5,7-Trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-on|2,5,7-trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-one
(1S)-1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-6,9-dihydro-1H-naphtho[2,3-c]pyran-6,9-dione|coronatoquinone
9H-Xanthen-9-one, 5-chloro-8-hydroxy-1,4-dimethoxy-3-methyl-
3-Chloro-1, 2, 4, 5-tetrahydroxy-7-methylanthraquinone
2-chloro-1-hydroxy-3,6-dimethoxy-8-methyl-xanthen-9-one|2-Chloro-3, 6-di-O-methylnorlichexanthone
16-bromo-(7E,11E,15E)-hexadeca-7,11,15-trien-5,13-diynoic acid
4-dechloro-8-O-methylthiomelin|5, 8-Di-Me ether-2-Chloro-1, 5, 8-trihydroxy-6-methylxanthone
5,6-anhydrolandomycinone
A natural product found in Streptomyces cyanogenus.
(Z)-4-hydroxy-3-(7-hydroxy-4-chromoyl)-hex-2-enedioic acid
rel-(1R,5S)-3-(1-acetoxybutyl)-4-bromo-5-methyl-5-methoxy-2(5H)-furanone
4-Hydroxy-3-methoxy-5-phenyl-1,8-naphthalic anhydride
Dihydromyricetin
A hexahydroxyflavanone that is the 2,3-dihydro derivative of myricetin. Dihydromyricetin, also known as ampelopsin or (2r,3r)-3,5,7,3,4,5-hexahydroxyflavanone, is a member of the class of compounds known as epigallocatechins. Epigallocatechins are compounds containing epigallocatechin or a derivative. Epigallocatechin is a flavan-3-ol containing a benzopyran-3,5,7-triol linked to a 3,4,5-hydroxyphenyl moiety. Dihydromyricetin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Dihydromyricetin can be found in a number of food items such as highbush blueberry, summer grape, sacred lotus, and sweet rowanberry, which makes dihydromyricetin a potential biomarker for the consumption of these food products. Hovenia dulcis has been used in traditional Japanese, Chinese, and Korean medicines to treat fever, parasitic infection, as a laxative, and a treatment of liver diseases, and as a hangover treatment. Methods have been developed to extract ampelopsin from it at large scales, and laboratory research has been conducted with the compound to see if it might be useful as a drug in any of the conditions for which the parent plant has been traditionally used . Isolated from flowers of Eugenia jambolana (jambolan). trans-3,3,4,5,5,7-Hexahydroxyflavanone is found in fruits. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
Ellagic acid hydrate
Lonidamine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000988 - Antispermatogenic Agents D011838 - Radiation-Sensitizing Agents C1744 - Multidrug Resistance Modulator D000970 - Antineoplastic Agents Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki: 2.5 μM). Lonidamine also inhibits aerobic glycolysis in cancer cells. Lonidamine can be used in the research of mitochondrial metabolism and inflammation, such as pulmonary fibrosis[1][2][3].
2-chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione
2-chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione_major
Fenirofibrate
C17H17ClO4 (320.08153120000003)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent
Gly-His-OH
C13H12N4O6 (320.07568119999996)
16-bromo-7E,11E,15E-hexadecatrien-5,13-diynoic acid
16-bromo-7E,11E,15Z-hexadecatrien-5,13-diynoic acid
1-[2,6-DINITRO-4-(TRIFLUOROMETHYL)PHENYL]PIPERAZINE
4-[[2-(trifluoromethyl)benzimidazol-1-yl]methyl]benzoic acid
C16H11F3N2O2 (320.07725819999996)
N-[5-Acetyl-2-(benzyloxy)phenyl]sulfuric diamide
C15H16N2O4S (320.08307360000003)
[4-[3,5-bis(trifluoromethyl)phenyl]phenyl]methanol
1-(5-BROMO-1H-INDOL-3-YL)-2-(PYRROLIDIN-1-YL)ETHANE-1,2-DIONE
3-(5-Bromo-2-hydroxyphenyl)-3-phenylpropanoic acid
3-(3-amino-1-(4-chlorophenyl)butan-2-yl)benzonitrile HCl salt
N-[6-[(2-chloro-4-hydroxyphenyl)imino]-4-methoxy-3-oxo-1,4-cyclohexadien-1-yl]acetamide
C15H13ClN2O4 (320.05638080000006)
Etomoxir (Na salt)
C15H18ClNaO4 (320.07912580000004)
Etomoxir((R)-(+)-Etomoxir) sodium salt is an irreversible inhibitor of carnitine palmitoyltransferase 1a (CPT-1a), inhibits fatty acid oxidation (FAO) through CPT-1a and inhibits palmitate β-oxidation in human, rat and guinea pig[1].
(2-(Benzyloxy)-3-bromo-5-methylphenyl)boronic acid
7-chloro 5-(2-chlorophenyl)-1,3-dihydro-2H-(1,4)-benzodiazepine-2-thione
C15H10Cl2N2S (319.99417200000005)
METHYL 3-(4-(ETHOXYCARBONYL)-3-FLUOROPHENYL)-2-FLUOROBENZOATE
Benzonitrile, 3-[(1R,2R)-2-amino-1-[(4-chlorophenyl)methyl]propyl]-, monohydrochloride, rel- (9CI)
(1S, 2S)-1,2-Bis(4-fluorophenyl)ethylenediamine dihydrochloride
bis(pentane-2,4-dionato-O,O)(propane-1,3-diolato-O,O)titanium
((7-Oxo-7H-benz(de)anthracen-3-yl)thio)acetic acid
4-[2-chloro-6-(3-nitrophenyl)pyrimidin-4-yl]morpholine
(4-((TERT-BUTYLDIMETHYLSILYL)OXY)-3,5-DICHLOROPHENYL)BORONIC ACID
C12H19BCl2O3Si (320.05735139999996)
4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenamine
Ethyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate
C15H13ClN2O4 (320.05638080000006)
Ethyl [(4-chloro-3-cyano-6-methoxy-7-quinolinyl)oxy]acetate
C15H13ClN2O4 (320.05638080000006)
4-Chloro-1-((3-(trifluoromethyl)phenoxy)Methyl)-1H-pyrazole-3-carboxylic acid
Benzonitrile, 3-[(1S,2S)-2-amino-1-[(4-chlorophenyl)methyl]propyl]-, hydrochloride (1:1)
5-(2-chlorophenyl)-7-ethyl-1H-thieno[2,3-e][1,4]diazepine-2(3H)-thione
1,4-Benzodioxin-2-methanol, 2,3-dihydro-, 4-methylbenzenesulfonate
C16H16O5S (320.07184060000003)
1-bromo-2-fluoro-4-(4-pentylphenyl)benzene
C17H18BrF (320.05758199999997)
7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-benzo-1,4-diazepin-2-one 4-oxide
(4R,5R)-2-Chloro-1,3-dimethyl-4,5-diphenyl-1-imidazolinium Chloride
Tenidap
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
ETHYL 2-(2-(((BENZYLOXY)CARBONYL)AMINO)THIAZOL-4-YL)ACETATE
C15H16N2O4S (320.08307360000003)
1-Butanesulfonamide,N-[4-(4-cyano-2,5-dihydro-5-oxo-3-furanyl)phenyl]-
C15H16N2O4S (320.08307360000003)
2-(4-Aminophenyl)-6-methyl-1,3-benzothiazole-7-sulfonic acid
2-(4-AMINO-BENZENESULFONYLAMINO)-3-PHENYL-PROPIONIC ACID
C15H16N2O4S (320.08307360000003)
4-Hydroxy-2-phenyl-6-quinolinesulfonic acid fluoride
C15H11FNO4S- (320.03927980000003)
N-(2-Formyl-4-nitro-phenyl)-4-methyl-benzenesulfonamide
1-[4-(6-METHYL-BENZOTHIAZOL-2-YL)-PHENYL]-PYRROLE-2,5-DIONE
Methyl (E)-2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate
C15H13ClN2O4 (320.05638080000006)
2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]acetic acid
1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 5-CHLORO-1-(PHENYLSULFONYL)-
1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-CHLORO-1-(PHENYLSULFONYL)-
1H-PYRROLO[2,3-B]PYRIDINE, 4-CHLORO-2-METHYL-1-[(2-METHYLPHENYL)SULFONYL]-
C15H13ClN2O2S (320.03862280000004)
2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone
2-Bromo-2-deoxy-3,4-dihydrothymidine
C10H13BrN2O5 (320.00077880000003)
chloropalladium(1+),(1Z,5Z)-cycloocta-1,5-diene,2-methanidyl-2-methylpropane
(2-IODO-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER
methyl 12-hydroxy-6-oxonaphtho[1,2-c]isochromene-11-carboxylate
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-3-methyl-1-[(4-methylphenyl)sulfonyl]-
C15H13ClN2O2S (320.03862280000004)
2-thia-6-azaspiro[3.3]heptane hemioxalate
C12H20N2O4S2 (320.08644400000003)
Benzene, 4-(bromomethyl)-1-cyclohexyl-2-(trifluoromethyl)-
2-(CHLOROMETHYL)-3-(4-CHLOROPHENYL)-2-METHYL-1,2,3,4-TETRAHYDROQUINAZOLIN-4-ONE
2-dimethoxyphosphinothioylsulfanyl-2-phenylacetic acid
2,6-Dichloro-9-(β-D-ribofuranosyl)-9H-purine
C10H10Cl2N4O4 (320.00790800000004)
2-butoxyethyl 2,4-dichlorophenoxyacetate
C14H18Cl2O4 (320.05820880000005)
5-(2-CHLORO-1,1-DIMETHYLETHYL)-3-[4-(TRIFLUOROMETHOXY)PHENYL]-1,2,4-OXADIAZOLE
4-amino-N-[3-[(2-hydroxyethyl)sulphonyl]phenyl]benzamide
C15H16N2O4S (320.08307360000003)
METHYL 5-(2-METHOXY-2-OXOETHYL)-1-(4-NITROPHENYL)-1H-1,2,3-TRIAZOLE-4-CARBOXYLATE
C13H12N4O6 (320.07568119999996)
4-(5-(3-(TRIFLUOROMETHYL)PHENYLAMINO)-4H-1,2,4-TRIAZOL-3-YL)PHENOL
C15H11F3N4O (320.08849119999996)
Encenicline
C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist > C73579 - Nicotinic Agonist
(5s)-2-{[(1s)-1-(2-Fluorophenyl)ethyl]amino}-5-Methyl-5-(Trifluoromethyl)-1,3-Thiazol-4(5h)-One
3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-4-one
5-Amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one
C16H11F3N2O2 (320.07725819999996)
7-(Benzyloxy)-4-(trifluoromethyl)-2H-chromen-2-one
2,3-Dihydro-5-chloro-2-oxo-3-(2-thienylcarbonyl)-1H-indole-1-carboxamide
3-Bromo-2,2-dimethyl-3,4-dihydro-2H-benzo(h)chromene-5,6-dione
N-(4-fluorophenyl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide
N-[4-[(4-hydroxyphenyl)-methylsulfamoyl]phenyl]acetamide
C15H16N2O4S (320.08307360000003)
[3-Methyl-4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-thiophen-2-ylmethanone
C15H16N2O2S2 (320.06531559999996)
1H-Indazole-3-carboxylic acid, 1-(3,4-dichlorobenzyl)-
2-[(6-chloro-1-benzotriazolyl)oxy]-N-(4-fluorophenyl)acetamide
C14H10ClFN4O2 (320.04762819999996)
3-(2-chloro-5-oxo-10-phenothiazinyl)-N-methyl-1-propanamine
8-Chloro-10-[3-(methylamino)propyl]-10h-phenothiazin-3-ol
5-(4-Methylphenyl)-2-methylsulfonyl-3-thiophen-2-yl-3,4-dihydropyrazole
C15H16N2O2S2 (320.06531559999996)
10-(3-Aminopropyl)-8-chlorophenothiazine-2,3-dione
C15H13ClN2O2S (320.03862280000004)
D004791 - Enzyme Inhibitors > D000067956 - Adenylyl Cyclase Inhibitors
2-(4,5-dihydrothiazol-2-ylthio)-N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]acetamide
2-Chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthraquinone
N-(5-Phosphopyridoxyl)-D-alanine
C11H17N2O7P (320.07733420000005)
An alanine derivative arising from reductive N-alkylation of D-alanine by pyridoxal-5-phosphate.
N-(5-Phosphopyridoxyl)-L-alanine
C11H17N2O7P (320.07733420000005)
An alanine derivative arising from reductive N-alkylation of L-alanine by pyridoxal-5-phosphate.
N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
N-(oxan-4-ylmethyl)-5-thiophen-2-ylimidazo[2,1-b][1,3,4]thiadiazol-2-amine
C14H16N4OS2 (320.07654859999997)
2-(6-methyl-2-pyridyl)-N-pyrimidin-4-yl-thieno[3,2-d]pyrimidin-4-amine
C16H12N6S (320.08441120000003)
2-(3,4-Dihydroxyphenyl)-3,5,7,8-tetrahydroxy-2,3-dihydrochromen-4-one
7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-1H,10H-pyrano[4,3-b]chromene-9-carboxylic acid
An organic heterotricyclic compound that is 1H,10H-pyrano[4,3-b]chromene substituted by hydroxy groups at positions 7 and 8, a methoxy group at position 1, a methyl group at position 3 and an oxo group at position 10. Isolated from Chaetomium funicola, it exhibits inhibitory activity against metallo-beta-lactamases.
5-O-(1-carboxylatovinyl)-3-phosphonatoshikimate
C10H9O10P-4 (319.99333440000004)
Octulose 8-phosphate
A ketooctose derivative that is D-glycero-D-altro-octulose carrying a single phosphate substituent at position 8.
(1-Hydroxy-2-(imidazo(1,2-a)-pyridin-3-yl)ethylidene)bisphosphonic acid monohydrate
D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
2-Amino-4-oxo-4-alpha-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-5,6, 7,8-tetrahydroxypterin
[(2R,3R,4S,5S)-3,4,5-trihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl] dihydrogen phosphate
[(2R,3R,4R,5R,6S,7R)-2,3,4,5,6,7-hexahydroxy-8-oxooctyl] dihydrogen phosphate
[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-methylphenoxy)oxolan-2-yl]methyl dihydrogen phosphate
C12H17O8P (320.06610120000005)
3-[[(1S)-4-amino-1-carboxy-4-oxobutyl]carbamoyl]-3-hydroxypentanedioic acid
C11H16N2O9 (320.08557659999997)
[(2R,3R)-2,3-dihydroxy-3-[(3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]propyl] dihydrogen phosphate
4-fluoro-N-(7-methyl-4-oxo-2-thieno[3,2-d][1,3]thiazinyl)benzamide
C14H9FN2O2S2 (320.00894659999994)
1-(3-Chlorophenyl)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)thiourea
C15H13ClN2O2S (320.03862280000004)
2-chloro-N-[(2-hydroxy-5-methylphenyl)carbamothioyl]benzamide
C15H13ClN2O2S (320.03862280000004)
2-[(3-Oxo-5-phenyl-1,2-dihydropyrazol-4-yl)-(3-thiophenyl)methyl]propanedinitrile
C17H12N4OS (320.07317820000003)
5-Nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester
2-(3-Methoxyphenyl)-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazole
C16H11F3N2O2 (320.07725819999996)
7-chloro-3-[2-(1-cyclohexenyl)ethyl]-2-sulfanylidene-1H-quinazolin-4-one
1-(1,2,3-Benzothiadiazol-5-yl)-3-(1-naphthalenyl)urea
C17H12N4OS (320.07317820000003)
N-(2-methoxyethyl)-1-methyl-2-oxo-6-benzo[cd]indolesulfonamide
C15H16N2O4S (320.08307360000003)
4-(2-furanyl)-N-(3-pyridinylmethyl)-6-(trifluoromethyl)-2-pyrimidinamine
C15H11F3N4O (320.08849119999996)
1-Naphthalen-2-yl-2-(9H-purin-6-ylsulfanyl)-ethanone
C17H12N4OS (320.07317820000003)
(2S,5R,6R)-6-[(4-hydroxybenzylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
C15H16N2O4S (320.08307360000003)
4-chloro-N-[(E)-[(E)-3-phenylprop-2-enylidene]amino]benzenesulfonamide
C15H13ClN2O2S (320.03862280000004)
[(E)-1-(4-methoxyphenyl)-3-phenylprop-2-enyl] hydrogen sulate
C16H16O5S (320.07184060000003)
N-[(Z)-(2-hydroxy-3-methoxy-5-nitrophenyl)methylideneamino]-2-(1,2,4-triazol-1-yl)acetamide
1-[(2,4-dichlorophenyl)methyl]-3-[(E)-2-phenylethenyl]urea
3-(3,4-Dihydroxyphenyl)-1-(2,3,4,5,6-pentahydroxyphenyl)prop-2-en-1-one
[(3S,4R,5R,6R,7R)-3,4,5,6,7,8-hexahydroxy-2-oxooctyl] dihydrogen phosphate
Phenyl-3-trimethylstannylpropyl sulfide
C12H24SSn (320.06206139999995)
Ampelopsin
(+)-dihydromyricetin is an optically active form of dihydromyricetin having (2R,3R)-configuration. It has a role as a metabolite, an antioxidant and an antineoplastic agent. It is a secondary alpha-hydroxy ketone and a dihydromyricetin. It is an enantiomer of a (-)-dihydromyricetin. Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus). Dihydromyricetin is a naturally occurring flavonoid found in the many plant species and is thought to be the active ingredient of several traditional Japanese, Chinese, and Korean medicines that are used to treat fever, parasite infections, liver diseases, and hangovers. Dihydromyricetin preparations have not been linked to instances of serum enzyme elevations or clinically apparent liver injury with jaundice. Dihydromyricetin is a natural product found in Vitis rotundifolia, Catha edulis, and other organisms with data available. An optically active form of dihydromyricetin having (2R,3R)-configuration. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
dTMP(2-)
A 2-deoxyribonucleoside 5-monophosphate(2-) obtained by deprotonation of the phosphate OH groups of dTMP; major species at pH 7.3.
5-O-(1-carboxylatovinyl)-3-phosphonatoshikimate
C10H9O10P (319.99333440000004)
The conjugate base of 5-O-(1-carboxyvinyl)-3-phosphoshikimic acid. It is an intermediate in the shikimate pathway.
PHENTHOATE
C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid
D004396 - Coloring Agents
6beta-[(p-hydroxybenzylidene)amino]penicillanic acid
C15H16N2O4S (320.08307360000003)
Penicillanic acid carrying a (p-hydroxybenzylidene)amino substituent at the 6beta position. It has been used as a hapten in the production of a generic monoclonal antibody for determining penicillin residues in milk.
(2E,4E)-2,4-Dihydroxy-4-[6-(4-hydroxyphenyl)-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene]but-2-enoate
2-chloro-7-hydroxy-3,9-dimethoxy-1-methylbenzo[c]chromen-6-one
4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid
(3s)-4,5,10-trihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione
4,5,10-trihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione
8-hydroxy-7-methoxy-10-phenyl-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione
(1s)-1-[(5r)-4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl]butyl acetate
1-chloro-2,4,5-trihydroxy-7-(hydroxymethyl)anthracene-9,10-dione
1,4-dihydroxy-6-methoxy-5,8-dioxo-3-(2-oxopropyl)naphthalene-2-carboxylic acid
2-o-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-phenylaceticacid
{"Ingredient_id": "HBIN006164","Ingredient_name": "2-o-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-phenylaceticacid","Alias": "NA","Ingredient_formula": "C15H12O8","Ingredient_Smile": "C1=CC(=C(C=C1C(=O)OC2=CC(=CC(=C2CC(=O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5767","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,5,7,2',6'-pentahydroxy flavonol
{"Ingredient_id": "HBIN007566","Ingredient_name": "3,5,7,2',6'-pentahydroxy flavonol","Alias": "NA","Ingredient_formula": "C15H12O8","Ingredient_Smile": "C1=CC(=C(C(=C1)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)(O)O)O","Ingredient_weight": "320.25 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT19413","TCMID_id": "31765","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129892149","DrugBank_id": "NA"}
5-(2-carboxy-3-hydroxy-5-methoxyphenyl)-4-methyl-6-oxopyran-2-carboxylic acid
ethyl (1r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-1-carboxylate
4-chloro-1,3,10-trihydroxy-8-methoxy-6-methyl-10h-anthracen-9-one
(1r)-1-[(5r)-4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl]butyl acetate
4-(2-carboxy-3-hydroxy-5-methoxyphenyl)-3-methyl-6-oxopyran-2-carboxylic acid
(1r)-dispiro[cyclopentane-1,2'-pyran-3',3''-[2,4]dioxatricyclo[7.3.1.0⁵,¹³]tridecane]-1''(13''),3,5'',7'',9'',11''-hexaene-2,6'-dione
(3r)-3-[(2r)-3,3-dichloro-2-hydroxypropyl]-8-hydroxy-6-methoxy-3,4-dihydro-2-benzopyran-1-one
dispiro[cyclopentane-1,2'-pyran-3',3''-[2,4]dioxatricyclo[7.3.1.0⁵,¹³]tridecane]-1''(13''),3,5'',7'',9'',11''-hexaene-2,6'-dione
12-hydroxy-4-methoxy-5-phenyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),4,9,11-pentaene-3,6-dione
(2z,4s)-4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid
bis(5-hydroxy-1h-indol-3-yl)ethane-1,2-dione
C18H12N2O4 (320.07970320000004)